The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22 - PubMed (original) (raw)
Multicenter Study
. 2007 Sep;125(9):1225-32.
doi: 10.1001/archopht.125.9.1225.
Affiliations
- PMID: 17846363
- DOI: 10.1001/archopht.125.9.1225
Multicenter Study
The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22
Age-Related Eye Disease Study Research Group et al. Arch Ophthalmol. 2007 Sep.
Abstract
Objective: To evaluate the relationship of dietary carotenoids, vitamin A, alpha-tocopherol, and vitamin C with prevalent age-related macular degeneration (AMD) in the Age-Related Eye Disease Study (AREDS).
Methods: Demographic, lifestyle, and medical characteristics were ascertained on 4519 AREDS participants aged 60 to 80 years at enrollment. Stereoscopic color fundus photographs were used to categorize participants into 4 AMD severity groups and a control group (participants with < 15 small drusen). Nutrient intake was estimated from a self-administered semiquantitative food frequency questionnaire at enrollment. Intake values were energy adjusted and classified by quintiles. The relationship between diet and AMD status was assessed using logistic regression analyses.
Results: Dietary lutein/zeaxanthin intake was inversely associated with neovascular AMD (odds ratio [OR], 0.65; 95% confidence interval [CI], 0.45-0.93), geographic atrophy (OR, 0.45; 95% CI, 0.24-0.86), and large or extensive intermediate drusen (OR, 0.73; 95% CI, 0.56-0.96), comparing the highest vs lowest quintiles of intake, after adjustment for total energy intake and nonnutrient-based covariates. Other nutrients were not independently related to AMD.
Conclusion: Higher dietary intake of lutein/zeaxanthin was independently associated with decreased likelihood of having neovascular AMD, geographic atrophy, and large or extensive intermediate drusen.
Comment in
- Lutein/zeaxanthin.
Hawkins WR. Hawkins WR. Arch Ophthalmol. 2008 Sep;126(9):1313; author reply 1313-4. doi: 10.1001/archopht.126.9.1313-a. Arch Ophthalmol. 2008. PMID: 18779501 No abstract available.
Similar articles
- Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group.
Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, et al. Seddon JM, et al. JAMA. 1994 Nov 9;272(18):1413-20. JAMA. 1994. PMID: 7933422 - Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study.
Chiu CJ, Milton RC, Klein R, Gensler G, Taylor A. Chiu CJ, et al. Ophthalmology. 2009 May;116(5):939-46. doi: 10.1016/j.ophtha.2008.12.025. Ophthalmology. 2009. PMID: 19410952 Free PMC article. - Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.
Wu J, Cho E, Willett WC, Sastry SM, Schaumberg DA. Wu J, et al. JAMA Ophthalmol. 2015 Dec;133(12):1415-24. doi: 10.1001/jamaophthalmol.2015.3590. JAMA Ophthalmol. 2015. PMID: 26447482 Free PMC article. - Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR, Lawrenson JG. Evans JR, et al. Cochrane Database Syst Rev. 2023 Sep 13;9(9):CD000254. doi: 10.1002/14651858.CD000254.pub5. Cochrane Database Syst Rev. 2023. PMID: 37702300 Free PMC article. Review. - Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis.
Ma L, Dou HL, Wu YQ, Huang YM, Huang YB, Xu XR, Zou ZY, Lin XM. Ma L, et al. Br J Nutr. 2012 Feb;107(3):350-9. doi: 10.1017/S0007114511004260. Epub 2011 Sep 8. Br J Nutr. 2012. PMID: 21899805 Review.
Cited by
- Prevalence and risk factors of early-stage age-related macular degeneration in patients examined at a health promotion center in Korea.
Moon BG, Joe SG, Hwang JU, Kim HK, Choe J, Yoon YH. Moon BG, et al. J Korean Med Sci. 2012 May;27(5):537-41. doi: 10.3346/jkms.2012.27.5.537. Epub 2012 Apr 25. J Korean Med Sci. 2012. PMID: 22563220 Free PMC article. - Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases.
Rusciano D, Bagnoli P. Rusciano D, et al. Medicina (Kaunas). 2023 Jul 20;59(7):1334. doi: 10.3390/medicina59071334. Medicina (Kaunas). 2023. PMID: 37512145 Free PMC article. Review. - Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients.
Kowluru RA, Kanwar M, Chan PS, Zhang JP. Kowluru RA, et al. Arch Ophthalmol. 2008 Sep;126(9):1266-72. doi: 10.1001/archopht.126.9.1266. Arch Ophthalmol. 2008. PMID: 18779489 Free PMC article. - Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia.
Satyanarayana A, Balakrishna N, Pitla S, Reddy PY, Mudili S, Lopamudra P, Suryanarayana P, Viswanath K, Ayyagari R, Reddy GB. Satyanarayana A, et al. PLoS One. 2011;6(11):e26747. doi: 10.1371/journal.pone.0026747. Epub 2011 Nov 1. PLoS One. 2011. PMID: 22069468 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical